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Abstract
Background: People with rheumatoid arthritis (RA) have an increased risk of falls. The foot is a common site of
pathology in RA and foot problems are reported in up to 90 % of patients with established disease. The aim of this
study was to determine whether foot and ankle characteristics are associated with falls in people with RA.
Methods: Adults with RA were recruited from rheumatology outpatient clinics in Auckland, New Zealand.
Participants reported whether they had fallen in the preceding year, and the number of falls. Clinical characteristics,
common fall risk factors, and foot and ankle variables were measured. Univariate parametric and non-parametric
analysis compared fallers and non-fallers on all variables to determine significant differences. Logistic regression
analysis identified variables independently associated with falls.
Results: Two hundred and one participants were prospectively recruited. At least one fall in the preceding 12-months
was reported by 119 (59 %) participants. Univariate analysis showed that fallers had significantly longer mean disease
duration, more co-morbid conditions, an increase in lower limb tender joints, higher midfoot peak plantar pressures
and were more likely to have a history of vascular disease than non-fallers. Fallers also reported greater difficulty with
activities of daily living, increased fear of falling and greater self-reported foot impairment. Logistic regression analysis
revealed that increased midfoot peak plantar pressures (odds ratio (OR) 1.12 [for each 20 kPa increase], 95 % confidence
interval (CI) 1.00-1.25), self-reported foot impairment (OR 1.17 [for each three point increase], 95 % CI 1.05-1.31) and
history of vascular disease (OR 3.22, 95 % CI 1.17-8.88) were independently associated with a fall in the preceding
12 months.
Conclusions: Elevated midfoot peak plantar pressures, self-reported foot impairment and vascular disease are associated
with falls in people with RA. Assessment of foot deformity, foot function and self-reported foot impairment may be of
benefit when considering falls prevention strategies in people with RA.
Trial registration: Australia New Zealand Clinical Trial Registry (trial ACTRN12612000597897).
Keywords: Rheumatoid arthritis, Falls, Fall risk factors, Feet, Balance, Disability, Impairment
Background
Falls represent an important burden to healthcare re-
sources worldwide and treatment of fall related injuries
accounts for a significant proportion of healthcare
spending [1, 2]. For individuals, loss of confidence and
independence as a consequence of falling can signifi-
cantly reduce quality of life. Education regarding fall risk
and prevention is fundamental to health and well-being
in older adults [3].
People with rheumatoid arthritis (RA) are at greater risk
of falling than healthy older adults [4]. RA is a chronic,
inflammatory, autoimmune disease characterised by sys-
temic inflammation, persistent synovitis and progressive
articular destruction [5]. Most synovial joints can be
affected, however, the peripheral joints are predominantly
involved, most often the small joints of the hands and feet,
and usually in a symmetrical distribution [6]. Previous
studies in people with RA have reported falls incidence
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ranging from 10 to 54 % [4, 7–12]. Fall risk factors
common to older people have been identified in people
with RA [4, 9–11, 13]. These include history of a previous
fall [4, 11], fear of falling [4], impaired general health [13],
number of co-morbid conditions [10], fatigue and
dizziness [4] and antihypertensive medication [9]. Fall risk
factors which may be RA disease-specific have also been
reported including activity limitation as measured by the
Health Assessment Questionnaire (HAQ) [4, 13], tender
joint count [4, 13], swollen joint count [9], 28 joint Disease
Activity Score (DAS28) [4], pain intensity [4, 11], number
of medications [4, 7], use of corticosteroids, psychotropic
medications [4] and antidepressants [7]. Decreased lower
extremity muscle strength [4] and impaired standing
balance [4, 9] have also been associated with falls in people
with RA.
The foot is a common site of pathology in RA, with
many patients reporting foot symptoms at initial diag-
nosis, and as many as 90 % of people with established
RA report current foot problems [6]. Postural stability
is also decreased in people with RA compared to the
non-RA population. As a result, people with RA have
difficulty maintaining postural control when undertak-
ing everyday activities [14]. Several studies in healthy
older adult populations have identified foot and ankle
characteristics which may impair balance and increase
the risk of falling [15–21]. The foot and ankle charac-
teristics related to fall risk factors in older adults
include lesser toe deformity [16], reduced ankle range
of motion [21], severe bunion deformity [21], pes pla-
novalgus foot-type [15], reduced plantar sensitivity
[15, 21], decreased toe strength [16, 21], disabling
foot pain [15, 17, 21], slower gait speed [22] and
increased peak plantar pressures and pressure–time
integrals [17].
There is a dearth of evidence regarding foot and ankle
characteristics and falls in people with RA. The aim of
this study was therefore to determine the foot and ankle
characteristics associated with falls in people with RA.
This paper reports the findings of a cross-sectional study
in adults with established disease. We compared fallers
and non-fallers, according to falls experienced in the
preceding 12 months, on a range of foot and ankle
measures and common falls risk factors.
Methods
Participants
We recruited participants from rheumatology outpatient
clinics in the wider Auckland region of the North Island,
New Zealand. All participants were English speaking
adults (18 years and older) with RA according to the
2010 American College of Rheumatology/European
League Against Rheumatism classification criteria [23].
Participants were excluded if they were non-ambulatory
or unable to attend a study visit at a specified clinic or
research facility. Participants were also excluded if they
were unable to read and understand the information
sheet or sign the consent form. Based on a previous falls
study involving 176 older adults [21], an a priori sample
size calculation, based on a 15 % dropout rate, 80 % power,
and a significance level of 5 %, indicated that 200 partici-
pants were needed. The study was conducted with the
approval of the Northern X Regional Ethics Committee
(reference NTX/11/12/114) and the Auckland University
of Technology Ethics Committee (reference 12/47).
Data collection
Participant characteristics were recorded including age,
gender, ethnicity and body mass index (BMI). Medical
records were accessed to confirm RA disease type,
disease duration, erosive foot disease (as evidenced by
radiographs), previous foot surgery, blood tests, medica-
tions and co-morbid conditions. All clinical assessments
were completed at a single baseline study visit by one
researcher (ABR). The researcher is a New Zealand
registered podiatrist with five years of clinical practice
experience and postgraduate research training. RA
disease activity was assessed by the number of tender
and swollen joints and calculation of the four variable
DAS28-CRP [24]. Activity limitation was assessed using
the HAQ-II [25]. Participants also completed the Short
Falls Efficacy Scale-International (Short FES-I) and the
Foot Impact Scale (FIS) questionnaires. The Short FES-I
consists of seven questions which assess fear of falling re-
lated to a range of daily activities [26]. The FIS comprises
two subscales for impairment/footwear (FISIF; range 0–21)
and activities/participation (FISAP; range 0–30) [27]. An
elevated FISIF or FISAP score indicates greater foot impair-
ment or activity limitation respectively, and a three point
change is considered to be clinically relevant [28, 29]. In
accordance with a previous study [28], scores of ≤6 were
considered mild, from 7 to 13 were considered moderate,
and ≥14 were considered severe for FISIF. For FISAP,
scores ≤9 were considered mild, 10–19 were consid-
ered moderate, and ≥20 were considered severe. Global
pain in the past week and current patient global assess-
ment of disease activity were recorded using a 100 mm
visual analogue scale (VAS). A score of 0 mm on the pain
scale indicated ‘No Pain’ and 100 mm indicated ‘Severe
Pain’. On the patient global assessment scale, a score of
0 mm indicated ‘Very Well’ and 100 mm indicated ‘Very
Unwell’. Participants were asked whether they had ever
visited a podiatrist, and if so, the frequency of podiatric
care received.
Assessment of foot and ankle characteristics included
foot problem score (FPS), plantar sensation, foot and
ankle muscle strength, ankle range of motion (ROM),
toe strength, gait speed, peak plantar pressure and
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postural stability. The FPS is calculated based on a
grading of hallux valgus [30], lesser toe deformity, hyper-
keratotic lesions, abnormal bony prominences and VAS
foot pain [19]. Plantar sensation at six sites [31] was
assessed as fine touch, using a 10 g monofilament, and
as vibration perception threshold, using a biothesiometer
[32, 33]. Foot and ankle muscle strength (dorsiflexion,
plantarflexion, inversion, eversion) was assessed using a
hand-held dynamometer (HHD) using the make-test, in
which the assessor resists the movement of the muscle
[34]. Ankle ROM was assessed by a modified lunge test
using an upright acrylic sheet to measure the angle
formed by the head of the fibula and the lateral malleolus
in relation to the horizontal plane [35]. Toe strength was
assessed using the Paper Grip Test whereby patients are
instructed to grip a business card while an assessor
attempts to pull it out from underneath the hallux and
lesser toes. [21]. Gait speed was assessed using the 6-m
walk test [19]. Participants were tested in the footwear
which they wore to the study visit and instructed to walk
at their usual speed. Peak plantar pressure was recorded
for both feet using a TekScan MatScan® (TekScan Inc,
South Boston, USA) pressure mat [17]. The foot was
divided into forefoot, midfoot and rearfoot for analysis.
The forefoot was defined as 50 % of foot length, the mid-
foot was 19 % and the rearfoot was 31 % of foot length as
previously reported [36]. Participants were tested in bare
feet using a 2-step protocol [17]. The MatScan® was also
used to assess postural stability which was measured as
postural sway (oscillations around the centre-of-mass) in
the anterior-posterior (AP) and medial-lateral (ML)
directions, during quiet standing [37]. Participants
were tested in bare feet with eyes open for 30 s in
quiet bipedal standing. Extrinsic fall risk factors were
also recorded including footwear worn to the study
visit, the use of visual aids and use of assistive
devices. Footwear type was identified using a list of 17
footwear styles adapted from a previous study [38] and
grouped into good, average and poor for reporting [39].
Falls data ascertainment
The primary outcome measure for the study was fall
history. The number of falls experienced during the pre-
ceding 12 months was recorded as “no falls”, “one fall”
or “more than one fall”. The Prevention of Falls Network
Europe (ProFaNE) definition of “an event that results in
a person coming to rest unintentionally on the ground
or other lower level” was used to identify falls [2]. We
modified the fall definition by adding, “not as a result of
a major intrinsic event or an overwhelming hazard”, as
per previous study [21] to exclude falls which were the
result of syncope or an external force. Falls data were
obtained by providing the participant with the fall defin-
ition and then asking, “In the past 12 months, have you
had any fall including a slip or trip in which you lost
your balance and landed on the floor or ground or lower
level?” Falls history was recorded at the end of the study
visit following completion of all clinical and foot and
ankle measures.
Statistical analysis
Participants were grouped as ‘fallers’ or ‘non-fallers’ based
on the 12-month fall history. Comparisons between
groups were made using independent samples stu-
dent’s t tests for normally distributed variables and
Mann–Whitney U tests for skewed data. Chi-square
tests of trend were used as appropriate to examine
differences between groups on categorical variables.
To identify factors independently associated with a
history of falls, a logistic regression model was cre-
ated using falls in the preceding 12 months as the
dependent variable. A limited number of predictor
variables were selected based on statistical significance
of P < 0.15 on univariate analysis. Where multicolli-
nearity (r ≥ 0.7) was present, the variable with the
lowest P value, or of greatest clinical relevance, was
retained. Multivariate binary logistic regression analyses
were conducted including the selected predictor variables
adjusting for age. The backward elimination method was
used to remove the variable with the highest P-value, in a
stepwise approach, until all remaining variables were
significant at P < 0.05. Statistical analysis was performed
using Statistical Package for Social Sciences V22.0 (IBM
Corp., New York, USA).
Results
Participant characteristics
Two-hundred and one participants were recruited into
the study and completed the baseline study visit. Base-
line clinical characteristics and common fall risk factors
for the participants are presented in Table 1. Participants
were predominantly female (n = 150, 75 %). The mean
(SD) age of female participants was 63 (11) years and
male participants was 68 (10) years. Most of the
participants (n = 161, 80 %) identified as European
and had well established RA, with mean (SD) disease
duration 16 (14) years. Sixty-nine percent had co-
morbid conditions with hypertension (n = 73, 36 %)
and osteoporosis (n = 39, 19 %) being the most com-
mon. Most participants (n = 175, 87 %) were taking
non-biologic disease modifying anti-rheumatic drugs
(DMARDs) and over one third (n = 74, 37 %) were taking
prednisone. Anti-hypertensive medication (n = 91, 45 %)
was also common. On the day of the study visit, partici-
pants had moderate disease activity and reported mild to
moderate disability, with mean (SD) scores: DAS28 3.38
(1.26) and HAQ-II 0.89 (0.62).
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Table 2 describes the foot and ankle characteristics in
the entire group. Foot disease was frequently observed;
62 % (n = 112) had radiographic erosions in the feet,
bunion deformity was present in 65 % (n = 130) and
Table 1 Clinical characteristics and common fall risk factors
(n = 201). Data presented as mean (SD) unless specified
Age 64.7 (11)
Women, n (%) 150 (75)
European, n (%) 161 (80)
Body Mass Index, Kg/m2 27.8 (5.3)
Disease duration, years 15.9 (13.6)
Disease type, n (%)
Rheumatoid factor positive 162 (81)
Anti-CCP antibodies positive 105 (76)
Seronegative 26 (13)
RA medications, n (%)
DMARD monotherapy 71 (35)
Combination DMARD therapy (≥2 DMARDs) 104 (52)
Biologics 33 (16)
Prednisone 74 (37)
Other medications, n (%)
Opiates 18 (9)
Anti-platelets 44 (22)
Anti-coagulants 11 (6)
Anti-hypertensive 91 (45)
Hypoglycaemias 16 (8)
Psychotropics 37 (18)
Number of medications 4.1 (2.0)
Number of co-morbidities 1.2 (1)
Co-morbid conditions, n (%)
Hypertension 73 (36)
Other vascular disease 29 (14)
Diabetes Mellitus 18 (9)
Parkinson’s disease 2 (1)
Osteoporosis 39 (19)
Depression or bipolar disorder 16 (8)
Patient self-reported pain (VAS 0–100), mm 39 (27)
Patient global (VAS 0–100), mm 36 (26)
Tender joint count (total) 11 (12)
Swollen joint count (total) 5 (7)
DAS28-CRP score 3.38 (1.26)
Short FES-I score (7–28) 12 (5)
HAQ-II score 0.89 (0.62)
Wears glasses or contact lenses, n (%) 181 (90)
Uses assistive device, n (%) 57 (28)
VAS visual analogue scale, DAS disease activity score, FES-I Falls Efficacy
Scale-International, HAQII Health Assessment Questionnaire
Table 2 Foot and ankle fall risk factors (n = 201). Data presented
as mean (SD) unless specified
Foot erosion on radiograph, n (%) 112 (62)
Previous foot surgery, n (%) 29 (21)
Presence of foot pain, n (%) 147 (73)
Foot pain (VAS 0–100), mm 32 (29)
Tender joint count (lower limb) 6.0 (7.2)
Swollen joint count (lower limb) 1.8 (3.4)
Presence of tender and/or swollen joints (lower limb), n (%) 148 (74)
Foot problem score 15 (8)
Pes planovalgus foot-type, n (%) 68 (34)
Presence of bunion deformity, n (%) 130 (65)
Monofilament sites felt (0–12) 10 (3)
Vibration perception threshold≥ 26 mV, n (%) 85 (43)
Foot muscle strength, N
Dorsiflexion 63 (33)
Plantarflexion 69 (29)
Inversion 33 (17)
Eversion 30 (15)
Ankle range of motion, degrees 58 (7)
Gait speed, m/s 1.07 (0.3)
Peak plantar pressure, kPa
Forefoot 310 (66)
Midfoot 113 (62)
Rearfoot 243 (69)
Failed paper grip test hallux, n (%) 101 (50)
Failed paper grip test lesser toes, n (%) 102 (50)
Toe strength hallux, N (%BW) 4.5 (2.5)
Toes strength lessor toes, N (%BW) 2.1 (1.2)
Eyes-open postural sway, mm
AP direction 20.9 (9.7)
ML direction 14.2 (8.7)
Eyes-closed postural sway, mm
AP direction 29.4 (12.9)
ML direction 17.4 (9.7)
Has seen a podiatrist before, n (%) 107 (53)
Receives regular podiatry treatment, n (%) 32 (16)
FISTOTAL score (0–51) 25 (12)
FISIF subscale score (0–21) 10 (5)
FISAP subscale score (0–30) 15 (9)
Good footwear type worn to study visit, n (%) 102 (51)
Average footwear type worn to study visit, n (%) 18 (9)
Poor footwear type worn to study visit, n (%) 81 (40)
VAS visual analogue scale, AP antero-posterior, ML medio-lateral, FISIF foot
impact scale impairment/footwear subscale; FISAP foot impact scale
activities/participation subscale
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34 % (n = 68) had pes planovalgus foot-type. Half of
the participants failed the paper grip test for the hal-
lux (n = 101, 50 %) and lesser digits (n = 102, 50 %)
and 43 % (n = 85) had a vibration perception thresh-
old greater than 26 mV, indicating presence of neur-
opathy. Seventy-three percent (n = 147) of participants
experienced foot pain in the past week, with a mean
(SD) of 32 (29) using a 100 mm VAS. On examin-
ation, 74 % (n = 148) presented with tender and/or
swollen lower limb joints. On the day of the study
visit, participants reported moderate levels of foot
impairment and disability, with mean (SD) score of
10 (5) for impairments/footwear (FISIF) and 15 (9) for
activities/participation (FISAP). Just over half of the partici-
pants (n = 102, 51 %) wore footwear classified as ‘good’ to
the study visit. Fifty-three percent (n = 107) had previously
visited a podiatrist but only 16 % (n = 32) received regular
podiatry treatment.
Univariate analysis comparing fallers and non-fallers
Of the 201 participants with RA, 119 (59 %) reported
one or more falls in the preceding 12 months. Of those
that fell, 46 (39 %) fell once (single-fallers) and 73 (61 %)
fell more than once (multiple-fallers). Age (P = 0.69)
and female sex (P = 0.58) were not associated with
falls. The results of univariate analysis comparing
non-fallers and fallers on other baseline measures are
presented in Table 3. Results shown are for compari-
sons with P < 0.05. Fallers had significantly longer
mean disease duration (P = 0.03), an increase in
lower limb tender joints (P = 0.04), more co-morbid
conditions (P = 0.02) and higher midfoot peak plantar
pressures (P = 0.007). There was a significant differ-
ence in HAQ-II score between the groups with fallers
reporting greater difficulty with the activities of daily
living, compared to non-fallers (P = 0.01). Fallers also re-
ported greater fear of falling with significantly higher short
FES-I scores (P = 0.002) than non-fallers. Foot disabil-
ity and impairment was greater in fallers compared to
non-fallers with significantly higher scores recorded
for the activities/participation subscale (FISAP) of the
Foot Impact Scale (P = 0.002). Compared to non-
fallers, those who fell were more likely to have a history
of vascular disease including stroke, ischemic heart disease,
arrhythmia and peripheral vascular disease (P = 0.03).
Multivariate analysis of predictive risk factors
Multivariate logistic regression analysis identified
associations between potential fall risk factors and
falls in the preceding 12-months. The results compar-
ing all fallers with non-fallers using logistic regression
analyses are shown in Table 4. Seventeen variables,
plus age, were entered into the original model includ-
ing: pes planovalgus foot-type, tender joint count
(lower limb), gait speed, foot problem score, hallux
strength, ankle range of motion, peak plantar pressure
midfoot, eyes closed AP sway, FISAP, disease duration,
DAS28-CRP, DMARD monotherapy, combination
DMARD therapy, number of medications, number of
co-morbid conditions, vascular disease and osteopor-
osis. To avoid multicollinearity, HAQ-II and FES-I
were excluded from the model as they were both
highly correlated (R ≥ 0.7) with FISAP. In addition,
total tender joint count was excluded as it was highly
correlated with tender joint count (lower limb). The
final model contained three variables which were
independently associated with a fall in the preceding
12-months (P < 0.05): history of vascular disease (odds
ratio (OR) 3.22, 95 % confidence interval (CI) 1.17-
8.88, P = 0.024), increased midfoot peak plantar
Table 3 Univariate analysis of non-fallers and fallersa. Data
presented as mean (SD) unless specified
Non-fallers
n = 82
Fallers
n = 119
P value
Clinical features
Disease duration 13.6 (12.8) 17.4 (13.9) 0.03
HAQ-II 0.76 (0.60) 0.98 (0.62) 0.01
Number of co-morbid conditions 0.96 (0.92) 1.33 (1.11) 0.02
Vascular disease, n (%) 6 (7) 23 (19) 0.03
Fear of falling (short FES-I) 11 (5) 13 (5) 0.002
Foot and ankle features
Tender joint count (lower limb) 4.98 (6.9) 6.63 (7.37) 0.04
Peak plantar pressure midfoot, kPa 100 (44) 122 (71) 0.007
Patient-reported foot impairment (FISAP) 12 (9) 16 (8) 0.002
aComparisons with P < 0.05 are shown
HAQ Health Assessment Questionnaire, FES-I Falls Efficacy Scale-International,
FISAP Foot Impact Scale Activities/Participation subscale
Table 4 Stepwise logistic regression analyses comparing fallers
(n = 119) and non-fallers (n = 82) on all predictor variables
adjusting for agea
Odds ratio (95 %
confidence interval)
P value
Age 0.99 (0.96-1.02) 0.500
Vascular disease 3.22 (1.17-8.88) 0.024
Peak plantar pressure midfoot 1.12 (1.00-1.25) 0.046
(for each 20kPa increase)
Foot Impairment FISAP 1.17 (1.05-1.31) 0.005
(for each 3 point increase)
aAssociations with P < 0.05 are shown
kPa = kilopascals, FISAP Foot Impact Scale Activities/Participation subscale
Variables included in the model: age, pes planovalgus foot-type, tender joint
count (lower limb), gait speed, foot problem score, hallux strength, ankle range
of motion, peak plantar pressure midfoot, eyes closed AP sway, FISAP, disease
duration, DAS28-CRP, DMARD monotherapy, combination DMARD therapy,
number of medications, number of co-morbid conditions, vascular disease
and osteoporosis
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pressure (OR 1.12 [for each 20kPa increase], 95 % CI
1.00-1.25, P = 0.046) and self-reported foot impair-
ment (OR 1.17 [for each tress point increase], 95 %
CI 1.05-1.31, P = 0.005).
Discussion
In this study, 59 % of participants reported at least one
fall during the preceding 12-months. This is much
higher than the 30 % reported for community dwelling
older adults [40] and is consistent with reports that
adults with RA are at increased risk of falling compared
to the non-RA population [4, 9, 11]. Previous studies in
RA populations have identified fall risk factors common
to older adults generally, as well as disease-specific fall
risk factors. The current study sought to extend our
understanding of fall risk in this group through the
inclusion of foot and ankle measures known to be
associated with falls in healthy older adults.
We found fallers to have higher peak plantar pressures
in the midfoot region compared to non-fallers. Midfoot
peak plantar pressure was also found to be independ-
ently associated with falls in the previous year, with the
odds of falling increasing by 12 % for each 20kPa
increase in pressure. Increased midfoot plantar pressures
have been reported in RA patients with pes planovalgus
(flatfoot) deformity, leading to adaptive changes which
may compromise stability and increase falls risk com-
pared to healthy controls [41]. Increased pressure at the
midfoot is also associated with a pronated foot posture,
which has previously been shown to impair postural
stability in healthy younger adults [42]. This is the first
study to assess plantar pressures as a potential fall risk
factor in people with RA. Our results suggest that meas-
urement of plantar pressures, at the midfoot, may be
useful in identifying people with RA at increased fall
risk. Plantar pressure systems are commonly used in
clinical practice to identify areas of high pressure which
may compromise tissue viability in patients with high
risk foot conditions [43]. Such equipment could also be
utilised to identify increased pressures at the midfoot, as
part of a fall risk assessment in patients with RA. In
clinical settings where pressure analysis equipment is
unavailable, the identification of a pes planovalgus foot-
type may suffice as an indicator of increased midfoot
pressures, particularly in the presence of callosities at
the talonavicular joint [41].
In agreement with previous studies [4, 11, 22], self-
reported disability and impairment (HAQ-II score) and
fear of falling (short FES-I score) were significantly
associated with increased risk of falling. Foot-related
disability and impairment were also found to be inde-
pendently associated with a history of falls. Specifically,
the odds of falling increased by 17 % for each three point
increase on the FISAP subscale. The FIS was designed
specifically to assess the impact of RA disease-related
foot involvement in terms of impairment, disability and
quality of life [27]. The current findings suggest that the
FIS, particularly the activities/participation subscale, may
also be useful in identifying and monitoring people with
RA with increased risk of falling. Clinical guidelines rec-
ommend the use of patient-reported outcome measures
(PROMs) in the management of foot health in people
with RA [44]. Our findings suggest that PROMs, includ-
ing the HAQ-II, the Short FES-I, and in particular, the
FIS may be also useful in identifying people with RA
with increased risk of falling and could be incorporated
as part of a regular fall risk assessment.
In the current study, lower limb tender joint count was
significantly higher for fallers compared to non-fallers.
Lower limb joint count included the knees, ankles and six-
teen joints in each foot. Several previous falls studies in RA
populations have assessed tender joints as a risk factor for
falls, with conflicting results [4, 9, 10, 13]. However, only
one study reported findings related to the lower extremities
[4]. In this study, Stanmore et al. [4] found that the pres-
ence of tender or swollen lower extremity joints was an
independent predictor of falls (OR 1.7). However, lower ex-
tremity joints included the hips, knees and ankles only [4].
Joint tenderness in RA is usually an indicator of synovitis
associated with active disease [45]. Although we found no
difference in swollen joint count between fallers and non-
fallers in the current study, synovitis in the small joints of
the feet can be difficult to detect clinically [46]. The feet are
often overlooked during consultations and it is possible that
active foot disease may go unnoticed [47]. Our findings
suggest that assessment of tenderness and swelling in the
lower limb joints, including the feet, may be important in
identifying people with RA at increased fall risk.
We found fallers to have longer RA disease duration
than non-fallers. As falls are generally associated with
older adults, clinicians may not identify younger people
with established RA, who are at increased fall risk. Num-
ber of co-morbid conditions was also associated with
increased falls risk, as observed in previous studies in RA
[10, 11]. In addition, vascular disease (including stroke,
ischemic heart disease, arrhythmia and peripheral vascular
disease) was independently associated with a history of
falling in the current study, with the odds of falling more
than tripling (OR 3.2) compared to those without vascular
disease. Co-morbid conditions, including cardiovascular
diseases, cancer, osteoporosis and depression, are com-
mon complications of RA [5]. Therefore, an association
between falls risk and co-morbid conditions, in particular
vascular disease, is an important finding.
In this study, falls were not associated with older age
or female sex which is in agreement with several other
studies in people with RA [4, 7, 9–11, 22]. In the general
population, older adults (over 65 years) and women
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experience significantly more falls than younger adults
and men, and falls rate increases with increasing age
[48]. It is possible that age related fall risk factors, such
as impaired general health, co-morbid conditions, fatigue
and history of prior falls, may occur in adults of all ages
with RA, thus mitigating age-related differences.
Strengths of the study are the large sample size and
the inclusion of a comprehensive range of validated
foot and ankle measures. The study has some limi-
tations. Firstly, the recruitment strategy involved
inviting clinic patients to participate in a study of fall
risk, so the frequency of falls may have been over-
estimated and may not be a true representation of
people with RA. Secondly, the retrospective recording
of falls may be subject to recall bias [49]. There was
no adjustment applied for multiple comparisons in
the univariate analysis. Finally, the cross-sectional design
prohibits determination of causality and it is not possible
to determine the temporal nature of observed associa-
tions. Prospective analysis of this cohort is ongoing to
provide more definitive conclusions regarding causes of
falls in people with RA.
Conclusions
Elevated midfoot peak plantar pressures, self-reported foot
impairment and history of vascular disease are independ-
ently associated with falls in the preceding 12-months in
people with RA. Assessment of foot deformity, foot func-
tion and self-reported foot impairment may therefore be
of benefit when considering falls prevention strategies in
people with RA.
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